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H. ZACHARIAE, M.D.t AND J. A. OATES, M.D.
Kinin peptides, which produce pain, vascular
permeability and vasodilatation, have been con-
sidered as possible mediators of the inflammatory
process (1, 2). Three kinins, methionyl-lysyl-
bradykinin, lysyl-bradykinin, and bradykinin have
been identified (3, 4, 5). These peptides are split
from plasma globulins by peptidases (Kallikreins)
found in plasma and in certain glandular tissues.
The kallikrein in plasma exists in an inactive
form, and must be activated to catalyze the for-
mation of kinins. In studies of the mechanism of
this activation process (6), we have found that
injection of plasma into the subcutaneous space
will lead to kinin formation. Because histamine
and other agents are thought to promote kinin
formation by increasing vascular permeability and
allowing plasma proteins into the interstitial fluid,
this would appear to be a good model system for
the study of formation of kinins in the extra-
vascular space.
In inflammation, the pH of the tissues become
slightly acid (7, 8). Accordingly, the following in-
vestigation was carried out to determine the effect
of pH on the kinin concentration in the experi-
mental kinin-forming system. The effect of pH on
kininase in rat plasma was also studied.
MATERIAL AND METHODs
Six female rats weighing approximately 200 g
were injected with mixtures of rat plasma and
buffer. Two rats were injected with physiological
saline and buffers. Each rat received from four to
seven injections of 0.5 or 1.0 ml mixtures which
had a buffer/plasma or buffer/saline ratio of 0.4
to 1.0. All buffers were 0.5 M phosphate buffers.
The pH of the mixtures ranged from 5.6 to 8.3.
The injections were performed with siliconized
syringes and siliconized hypodermic needles (No.
20) with four perforations in the shafts. The
needles were inserted into the subcutaneous tissue
at least 2 cm apart. The experimental mixtures
were left in the tissue for exactly 5 minutes, and
then were withdrawn through the same needles by
negative pressure maintained from the syringe
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and gentle massage of the tissue. The recovered
fluid, ranging from 10 to 85 per cent of the in-
jected material, was immediately added to ap-
proximately 3 volumes of boiling absolute alcohol
and boiled for 4 minutes. The preparations were
centrifuged, the precipitate washed with 1 ml 75
per cent ethanol and again centrifuged. The com-
bined first and second supernatants were evapo-
rated to dryness and assayed on the estrus uterus
of the rat for kinin activity (9).
In two of the above experiments, ineubations
of the same rat plasma and various phosphate
buffers also were performed simultaneously in
vitro; 0.5 ml plasma was incubated for 5 minutes
with 0.2 ml buffer at 37° C in polyethylene tubes.
The amount of kinin present in the rat plasma
prior to incubation was also investigated.
The effect of pH on the activity of rat plasma
kininase was demonstrated by incubating 500 mpeg
synthetic bradykinin with a mixture of 0.5 ml
plasma and 0.2 ml buffer for 2½, 5 or 15 minutes
at 37° C. Incubations were ended by boiling with
absolute alcohol. The assay procedures used were
the same as in the in vieo studies.
RESULTS
The data summarized in Fig. 1 show that the
maximum kinin levels in rat subcutaneous tissue
were found when the injected plasma had a pH
between 5.8 and 6.2. In each of five experiments
it was possible to determine a maximum with a
decrease of kinin formed when either increasing
or lowering the pH. In one experiment, not illus-
trated in Fig. 1, the maximum was found at the
lowest pH studied (pH 6.0), in which kinin ac-
tivity corresponding to 123 mpeg bradykinin/ml
was measured; at pH 7.0, 36 mp.g/ml was found
and at pH 7.4, 48 mzg/ml. In the control studies,
injections of saline and buffer produced either no
kinin or only negligible amounts. Kinins were not
found in measurable amounts in the rat plasma
prior to injection. Neither were appreciable
amounts of kinin found after rat plasma was in-
cubated in vitro with phosphate buffers ranging
from 5.6 to 8.3.
The studies on the effect of pH on the kininase
activity of rat plasma revealed a marked reduction
in activity when pH was lowered (Fig. 2).
DISCUSSION
The results of this study indicate that a slightly
acid pH greatly favors the accumulation of plasma
kinins m rat subcutaneous tissue. Although the
493
0'
E
a
D
-JIi
a
LUI-
C-)C
I—
><
LU
z
I-
>
I—0C
z
z
effect of pH on kinins in tissue is complex (2),
the investigation on rat plasma kininase suggests
that a major contribution to this accumulation
may be a reduction in kininase activity. When the
pH of rat plasma was reduced from 82 to 5.8,
kininase activity was markedly decreased. For in-
stance, in the 2.5 minute incubation study, the in-
activation of bradykinin was decreased from al-
most 100 per cent to less than 50 per cent. The
effect of pH on rat plasma kininase corresponds
to the findings with kininase from dog plasma (10)
and human plasma (6).
The studies in vitro show that the kinin formed
in the tissue does not result solely from activation
of kallikrein in the rat plasma by acidification or
dilution with buffer.
Kinin formation may follow an activation of
rat plasma kallikrein from some unknown factor
in the tissue such as dilution or may result from
the action of tissue kallikrein on plasma globu-
lins. Whether the slightly acid pH of injected ma-
terial favors the activation of the rat tissue kalli-
krein is not certain. Human serum contains a
kallikrein inhibitor with an activity optimum near
pH 7.5 while horse serum inhibitor has an opti-
mum near pH 5 ( 11).
The control studies with physiological saline and
buffers demonstrate that the kinins measured in
the tissues derived mainly from the injected
plasma and not from plasma escaped from the
vascular system. This suggests that a slight lower-
ing of pH is not alone sufficient to initiate kinin
formation in subcutaneous tissue. In inflammation,
where the pH of the tissues becomes slightly acid
(7, 8), mechanical injury or the release of such
vasoactive substances as histamine or 5-hydroxy-
tryptamine may initiate vascular permeability,
thus permitting plasma proteins to enter the tis-
sues. In the extravascular space, plasma may be
activated and in slightly acid pH of inflammed
tissue, decreasing kininase activity will favor the
accumulation ef kinins.
5UMMAaY
Analyses of kinin in rat subcutaneous tissue
following injection of rat plasma revealed maxi-
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Fio. 1. The effect of pH on kinin activity in rat subcutaneous tissue following injec-
tions of 0.5 or 1.0 ml of mixtures of rat plasma or physiological saline and 0.5 M phosphate
buffers. Each curve represents an experiment in one rat. Each X represents a single value
obtained from 2 separate control experiments with the saline-buffer mixture.
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Fio. 2. The effect of pH on kininase activity in
0.5 ml rat plasma incubated with 02 ml 0.5 M
phosphate buffers and 500 mpg synthetic brady-
kinin.
mum amounts when the injected plasma had a pH
of 5.8 to 6.2. Only trace amounts of kinin were
found when buffered saline was injected or when
rat plasma was incubated with the same buffers
in vitro.
Investigations on the effect of pH on rat plasma
kininase showed a marked reduction in activity
when pH was lowered, indicating that a major
contribution to the increase in kinin formed may
he a decrease in kininase activity.
It is suggested that the findings are of signifi-
cance in inflammatory conditions where pH is
slightly lowered.
Synthetic bradykinin was generously supplied
by Sandoz Pharmaceuticals, Division of Sandoz,
Incorporated, Hanover, New Jersey.
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